ArticleTomography (Ann Arbor, Mich.)2026
DenseViT-OCT: A Hybrid CNN-Transformer Architecture with Multi-Scale Dense Feature Aggregation for Automated Epiretinal Membrane Severity Classification.
Article in Tomography (Ann Arbor, Mich.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND/
objectivesEpiretinal membrane (ERM) is a common vitreoretinal disorder characterized by fibrocellular proliferation on the inner retinal surface, often leading to progressive visual impairment. Accurate grading of ERM severity using optical coherence tomography (OCT) is critical for treatment planning and surgical decision-making; however, manual grading is labor-intensive and subjective. This study aims to develop an automated and reliable deep learning-based method for ERM severity classification.
methodsWe propose DenseViT-OCT, a hybrid deep learning model that integrates dense convolutional neural networks (CNN) and vision transformers (ViT). The model introduces three key modules: Multi-Scale Dense Feature Aggregation (MDFA) for capturing hierarchical features across multiple spatial scales, Adaptive Feature Calibration (AFC) for enhancing feature discrimination through channel and spatial attention, and Cross-Attention Feature Fusion (CAFF) for enabling bidirectional interaction between convolutional and transformer representations. The model was trained and evaluated on 2195 OCT B-scan images obtained from 397 patients.
resultsDenseViT-OCT achieved an overall accuracy of 94.76% on the internal four-class test set, outperforming 19 benchmark models, including ConvNeXt, EfficientNet, ViT, and Swin Transformers. The model demonstrated balanced performance with a macro-averaged precision of 93.76%, recall of 93.22%, F1-score of 93.47%, Cohen's kappa of 92.62%, and macro-Area Under the Curve (AUC) of 98.95%. Ablation experiments confirmed the contribution of the proposed MDFA, AFC, CAFF, and deep supervision components, with the full model consistently outperforming reduced variants and standalone DenseNet121 and ViT-B/16 backbones. In repeated experiments across five random seeds, DenseViT-OCT also achieved the best mean accuracy (0.9399 ± 0.0052). External validation on the public multicenter OCTDL dataset, performed as binary ERM-versus-normal classification because of label availability, yielded 90.76% accuracy and 97.61% AUC, indicating promising generalization beyond the development cohort.
conclusionsDenseViT-OCT provides a robust framework for automated ERM severity classification from OCT B-scans. The combination of local CNN features, global transformer context, and dedicated fusion modules improves classification performance and yields clinically meaningful error patterns. Although further stage-wise multicenter validation, volumetric OCT analysis, and prospective clinical assessment are required, the proposed method shows promise as a research-oriented decision-support framework for B-scan-level ERM assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.